Apolipoprotein C-I is an APOE Genotype-dependent Suppressor of Glial Activation

Overview

Journal J Neuroinflammation

Publisher Biomed Central

Date 2012 Aug 14

PMID 22883744

Citations 24

Authors

Eiron Cudaback

Xianwu Li

Yue Yang

Thomas Yoo

Kathleen S Montine

Suzanne Craft

Thomas J Montine

Christopher Dirk Keene

Affiliations

Soon will be listed here.

Abstract

Background: Inheritance of the human ε4 allele of the apolipoprotein (apo) E gene (APOE) significantly increases the risk of developing Alzheimer's disease (AD), in addition to adversely influencing clinical outcomes of other neurologic diseases. While apoE isoforms differentially interact with amyloid β (Aβ), a pleiotropic neurotoxin key to AD etiology, more recent work has focused on immune regulation in AD pathogenesis and on the mechanisms of innate immunomodulatory effects associated with inheritance of different APOE alleles. APOE genotype modulates expression of proximal genes including APOC1, which encodes a small apolipoprotein that is associated with Aβ plaques. Here we tested the hypothesis that APOE-genotype dependent innate immunomodulation may be mediated in part by apoC-I.

Methods: ApoC-I concentration in cerebrospinal fluid from control subjects of differing APOE genotypes was quantified by ELISA. Real-time PCR and ELISA were used to analyze apoC-I mRNA and protein expression, respectively, in liver, serum, cerebral cortex, and cultured primary astrocytes derived from mice with targeted replacement of murine APOE for human APOE ε3 or ε4. ApoC-I direct modulation of innate immune activity was investigated in cultured murine primary microglia and astrocytes, as well as human differentiated macrophages, using specific toll-like receptor agonists LPS and PIC as well as Aβ.

Results: ApoC-I levels varied with APOE genotype in humans and in APOE targeted replacement mice, with ε4 carriers showing significantly less apoC-I in both species. ApoC-I potently reduced pro-inflammatory cytokine secretion from primary murine microglia and astrocytes, and human macrophages, stimulated with LPS, PIC, or Aβ.

Conclusions: ApoC-I is immunosuppressive. Our results illuminate a novel potential mechanism for APOE genotype risk for AD; one in which patients with an ε4 allele have decreased expression of apoC-I resulting in increased innate immune activity.

Citing Articles

A Novel Method to Disentangle Tightly Linked Risk and Resilience Genes for Brain Disorders: Application to Alzheimer's Disease.

Barnett E, Hess J, Hou J, Escott-Price V, Fennema-Notestine C, Kremen W medRxiv. 2025; .

PMID: 40061341 PMC: 11888503. DOI: 10.1101/2025.02.26.25322962.

Circadian Regulation of Apolipoproteins in the Brain: Implications in Lipid Metabolism and Disease.

Lee C, Murrell C, Chu A, Pan X Int J Mol Sci. 2023; 24(24).

PMID: 38139244 PMC: 10743770. DOI: 10.3390/ijms242417415.

Identification of Plasma Proteins as Biomarkers for Mild Cognitive Impairment and Alzheimer's Disease Using Liquid Chromatography-Tandem Mass Spectrometry.

Inoue M, Suzuki H, Meno K, Liu S, Korenaga T, Uchida K Int J Mol Sci. 2023; 24(17).

PMID: 37685872 PMC: 10488247. DOI: 10.3390/ijms241713064.

Lipoprotein Metabolism, Protein Aggregation, and Alzheimer's Disease: A Literature Review.

Grao-Cruces E, Claro-Cala C, Montserrat-de la Paz S, Nobrega C Int J Mol Sci. 2023; 24(3).

PMID: 36769268 PMC: 9918279. DOI: 10.3390/ijms24032944.

Sex and APOE Genotype Alter the Basal and Induced Inflammatory States of Primary Astrocytes from Humanized Targeted Replacement Mice.

Mhatre-Winters I, Eid A, Han Y, Tieu K, Richardson J ASN Neuro. 2023; 15:17590914221144549.

PMID: 36604975 PMC: 9982390. DOI: 10.1177/17590914221144549.

References

Galasko D, Montine T . Biomarkers of oxidative damage and inflammation in Alzheimer's disease. Biomark Med. 2010; 4(1):27-36. PMC: 2850111. DOI: 10.2217/bmm.09.89. View

Linton M, Gish R, HUBL S, Butler E, Esquivel C, Bry W . Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J Clin Invest. 1991; 88(1):270-81. PMC: 296029. DOI: 10.1172/JCI115288. View

Michelucci A, Heurtaux T, Grandbarbe L, Morga E, Heuschling P . Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol. 2009; 210(1-2):3-12. DOI: 10.1016/j.jneuroim.2009.02.003. View

Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K . Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer. 1980; 26(2):171-6. DOI: 10.1002/ijc.2910260208. View

Drigalenko E, Poduslo S, Elston R . Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease. Neurology. 1998; 51(1):131-5. DOI: 10.1212/wnl.51.1.131. View

Schippers E, Berbee J, van Disseldorp I, Versteegh M, Havekes L, Rensen P . Preoperative apolipoprotein CI levels correlate positively with the proinflammatory response in patients experiencing endotoxemia following elective cardiac surgery. Intensive Care Med. 2008; 34(8):1492-7. PMC: 2491416. DOI: 10.1007/s00134-008-1077-9. View

Lee Y, Han S, Nam S, Oh K, Hong J . Inflammation and Alzheimer's disease. Arch Pharm Res. 2010; 33(10):1539-56. DOI: 10.1007/s12272-010-1006-7. View

Naj A, Jun G, Beecham G, Wang L, Vardarajan B, Buros J . Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011; 43(5):436-41. PMC: 3090745. DOI: 10.1038/ng.801. View

Cudaback E, Li X, Montine K, Montine T, Keene C . Apolipoprotein E isoform-dependent microglia migration. FASEB J. 2011; 25(6):2082-91. PMC: 3101033. DOI: 10.1096/fj.10-176891. View

10.

Poduslo S, Neal M, Herring K, Shelly J . The apolipoprotein CI A allele as a risk factor for Alzheimer's disease. Neurochem Res. 1998; 23(3):361-7. DOI: 10.1023/a:1022409617539. View

11.

Berbee J, van der Hoogt C, Kleemann R, Schippers E, Kitchens R, van Dissel J . Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsis. FASEB J. 2006; 20(12):2162-4. DOI: 10.1096/fj.05-5639fje. View

12.

Shachter N . Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr Opin Lipidol. 2001; 12(3):297-304. DOI: 10.1097/00041433-200106000-00009. View

13.

Mackenzie I . Activated microglia in dementia with Lewy bodies. Neurology. 2000; 55(1):132-4. DOI: 10.1212/wnl.55.1.132. View

14.

Bsibsi M, Ravid R, Gveric D, van Noort J . Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol. 2002; 61(11):1013-21. DOI: 10.1093/jnen/61.11.1013. View

15.

Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T . Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 1982; 42(4):1530-6. View

16.

van Ree J, Van Den Broek W, van der Zee A, Dahlmans V, Wieringa B, Frants R . Inactivation of Apoe and Apoc1 by two consecutive rounds of gene targeting: effects on mRNA expression levels of gene cluster members. Hum Mol Genet. 1995; 4(8):1403-9. DOI: 10.1093/hmg/4.8.1403. View

17.

Westerterp M, de Haan W, Berbee J, Havekes L, Rensen P . Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL. J Lipid Res. 2006; 47(6):1203-11. DOI: 10.1194/jlr.M500434-JLR200. View

18.

Sullivan P, Mezdour H, Aratani Y, Knouff C, Najib J, Reddick R . Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem. 1997; 272(29):17972-80. DOI: 10.1074/jbc.272.29.17972. View

19.

Riddell D, Zhou H, Atchison K, Warwick H, Atkinson P, Jefferson J . Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J Neurosci. 2008; 28(45):11445-53. PMC: 6671315. DOI: 10.1523/JNEUROSCI.1972-08.2008. View

20.

Berbee J, Vanmierlo T, Abildayeva K, Blokland A, Jansen P, Lutjohann D . Apolipoprotein CI knock-out mice display impaired memory functions. J Alzheimers Dis. 2010; 23(4):737-47. DOI: 10.3233/JAD-2010-100576. View